[Preliminary study on the efficacy and safety of oral sildenafil in pulmonary arterial hypertension in China].

@article{Xiong2011PreliminarySO,
  title={[Preliminary study on the efficacy and safety of oral sildenafil in pulmonary arterial hypertension in China].},
  author={Chang-ming Xiong and Jianguo He and Xian-ling Lu and Guang-liang Shan and Bing-xiang Wu and Xian-yang Zhu and Guang-hua Wu and Xiaofeng Zeng and Tao Guo and Zhihong Liu and Xin-hai Ni and Xian-sheng Cheng and Qing Gu and Zhi-hui Zhao and Hong-yan Tian and Wei-Min Li and Duan-zhen Zhang and Cheng Zhang and Meng-tao Li and Hong-Ming Liu and Ya-juan Guo and Jie-yan Shen and Wei-jun Zhang and Shuang Liu and Da-xin Zhou and Chun-de Bao and S A Huang and Jian-ying Chen and Wei-Feng Wu and Kai Huang and Chang-ling Li and Lihua Wang and Bei He},
  journal={Zhonghua yi xue za zhi},
  year={2011},
  volume={91 6},
  pages={370-4}
}
OBJECTIVE Sildenafil has been shown to be effective in pulmonary arterial hypertension (PAH). However, the impact of sildenafil on PAH has been under-investigated in China. The aim of the present study was to evaluate the efficacy and safety of oral sildenafil in PAH patients in China. METHODS In this prospective, open-label and multi-center study, 90… CONTINUE READING